Kalydeco
These highlights do not include all the information needed to use KALYDECO safely and effectively. See full prescribing information for KALYDECO. KALYDECO (ivacaftor) tablets, for oral useKALYDECO (ivacaftor) oral granulesInitial U.S. Approval: 2012
0ab0c9f8-3eee-4e0f-9f3f-c1e16aaffe25
HUMAN PRESCRIPTION DRUG LABEL
Oct 16, 2023
Vertex Pharmaceuticals Incorporated
DUNS: 602478257
Products 6
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
ivacaftor
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (9)
ivacaftor
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (9)
ivacaftor
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (9)
ivacaftor
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (9)
ivacaftor
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (9)
ivacaftor
Product Details
FDA regulatory identification and product classification information